Outlook Therapeutics is a late‑stage biopharmaceutical company developing and commercialising ONS‑50 Sign up to read more
Profile updated Aug 2026
No filings found for this company.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| OUTLOOK THERAPEUTICS, INC.CORP | ORDINARY 1 GBP | 1,000 | 100.0% |
Companies with the most similar business descriptions.
Accounts not filed